(Q38061182)

28 August 2017

1 reference

title

Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review (English)

1 reference

28 August 2017

2

1 reference

28 August 2017

Arseniy E Yuzhalin

1

1 reference

28 August 2017

publication date

1 January 2012

1 reference

Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews

28 August 2017

published in

1 reference

28 August 2017

volume

30

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

287-322

1 reference

Inherited variations in the SOD and GPX gene families and cancer risk

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase: friend and foe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase: new polymorphisms and relation with lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Free radicals, metals and antioxidants in oxidative stress-induced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Myeloperoxidase promotor polymorphism and risk of hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

21 January 2018

Human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Gene therapy to prevent organophosphate intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Lipid peroxidation, free radical production and antioxidant status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

The molecular basis of the human serum paraoxonase activity polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

A common mutation in paraoxonase-2 results in impaired lactonase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Brain tumours and exposure to pesticides: a case-control study in southwestern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Effect of organophosphorus insecticides and their metabolites on astroglial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Oxidative response gene polymorphisms and risk of adult brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Hypochlorous Acid-Induced Base Modifications in Isolated Calf Thymus DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

Possible Risk Reduction in Esophageal Cancer Associated with MPO-463 A allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.731957

10.1080/10590501.2012.731957

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference